• Science & Technology

Wasting syndrome: What is cachexia?

Cachexia is a complex syndrome which has puzzled researchers for decades. But with new research from Cancer Grand Challenges, we could be close to uncovering its mysteries. Cachexia is a complex syndrome which has puzzled researchers for decades. But with new research from Cancer Grand Challenges, we could be close to uncovering its mysteries.

19 June 2023

• For Researchers

Pearls of Grand Challenge wisdom

We hear from two Cancer Grand Challenges team leads with their thoughts on forming and running a team. We hear from two Cancer Grand Challenges team leads with their thoughts on forming and running a team.

16 June 2023

• Health & Medicine

Risk of dying from early invasive breast cancer down by around two-thirds in the last 20 years

Today, more than 90% of women diagnosed with early-stage breast cancer will survive for 5 years or more, according to research we funded. Today, more than 90% of women diagnosed with early-stage breast cancer will survive for 5 years or more, according to research we funded.

13 June 2023

• Health & Medicine

Age: the forgotten cancer risk factor?

Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight.  Ageing is often the ‘forgotten’ cancer risk factor, overshadowed by preventable risk factors like smoking and obesity. Now, Cancer Grand Challenges are bringing bringing the ‘forgotten’ cancer risk factor into the spotlight. 

29 May 2023

• Science & Technology
• Health & Medicine

Stopping neuropathy – one of chemotherapy’s most challenging side effects

Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that. Chemotherapy-induced peripheral neuropathy (CIPN) is caused by cancer treatment, but there's no way to treat it. Our work is changing that.

22 May 2023

• Health & Medicine

FOCUS4: Learning from a landmark clinical trial

FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again.  FOCUS4 was a large-scale trial investigating new treatments in people with advanced or metastatic colorectal cancer. Running it may not have been without its challenges, but the learnings it provided us with are invaluable if we're to run trials like it again. 

25 April 2023

• Science & Technology
• Health & Medicine

3 ways we're helping teenagers and young adults with cancer

Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them. Teenagers and young adults with cancer have to deal with unique challenges. We're using our expertise to help tackle them.

18 April 2023

• Health & Medicine

Children’s cancer charities team up for tomorrow’s treatments

We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people. We're helping treble funding for paediatric Experimental Cancer Medicine Centres, paving the way to more effective and less toxic treatments for children and young people.

3 April 2023

• For Researchers

A career forged in team science

We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…    We spoke to Mariam Jamal-Hanjani and asked her to reflect on a career embedded in large-scale, collaborative and ambitious projects…   

10 March 2023

• Health & Medicine

Our nurses answer your frequently asked questions about cancer

Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions. Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions.

2 March 2023

• Science & Technology

The ecDNA story – catching the mastermind behind cancer evolution

Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it. Aggressive cancers use ecDNA to evolve quickly and resist treatment. This is how we found that out, and how we're going to stop it.

20 February 2023

• For Researchers

A real Eureka moment for translation

We hear how CRUK researchers got on at the Eureka international course on translational medicine in Sicily. We hear how CRUK researchers got on at the Eureka international course on translational medicine in Sicily.

10 February 2023